ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,891Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 97

$605K Total Retail Price of All Prescriptions

Rank: 22 out of 97

546 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 546 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 546 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,546 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 656 564 1 1
SIMVASTATIN 423 373 2 2
FUROSEMIDE 407 396 3 3
LISINOPRIL 320 288 4 4
METOPROLOL SUCCINATE 312 291 5 8
AMLODIPINE BESYLATE 282 264 6 6
OMEPRAZOLE 266 207 7 5
HYDROCHLOROTHIAZIDE 210 192 8 9
CITALOPRAM HBR 205 201 9 20
TRAMADOL HCL 196 176 10 21
GLIMEPIRIDE 195 187 11 39
BISOPROLOL-HYDROCHLOROTHIAZIDE 194 178 12 102
METOPROLOL TARTRATE 188 169 13 7
WARFARIN SODIUM 180 177 14 11
ALENDRONATE SODIUM 163 155 15 19
LOSARTAN POTASSIUM 160 149 16 13
SERTRALINE HCL 146 130 17 16
ATORVASTATIN CALCIUM 146 119 17 14
POTASSIUM CHLORIDE 136 128 19 10
GABAPENTIN 134 122 20 18
MELOXICAM 130 116 21 87
ATENOLOL 129 120 22 15
TRIAMTERENE-HCTZ 128 124 23 30
DONEPEZIL HCL 127 127 24 24
METFORMIN HCL ER 124 115 25 89
ZOLPIDEM TARTRATE 119 105 26 32
PRAVASTATIN SODIUM 116 104 27 28
HYDROCODONE-ACETAMINOPHEN 95 81 S3 28 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 89 29 36
SPIRONOLACTONE 91 78 30 33
LOSARTAN-HYDROCHLOROTHIAZIDE 89 73 31 49
LANTUS SOLOSTAR 89 68 31 41
MIRTAZAPINE 80 78 33 35
PEN NEEDLE 79 59 34 57
CLOPIDOGREL 76 73 35 34
DILTIAZEM 24HR ER 76 76 35 69
PANTOPRAZOLE SODIUM 71 70 37 53
METFORMIN HCL 71 65 37 12
NAMENDA 63 63 39 38
LACTULOSE 63 38 39 103
CIPROFLOXACIN HCL 61 57 41 60
ALLOPURINOL 61 47 41 22
PROAIR HFA 61 51 41 76
HUMALOG 59 56 44 77
CLONIDINE HCL 59 36 44 72
LYRICA 58 52 46 100
ADVAIR DISKUS 57 47 47 40
PAROXETINE HCL 55 41 48 56
RISPERIDONE 54 30 49 70
LANTUS 53 36 50 43
PREDNISONE 53 48 50 23
TRAZODONE HCL 52 47 52 42
NOVOLOG FLEXPEN 52 13 52 74
PLAVIX 51 50 54 46
INSULIN SYRINGE 50 42 55 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.